# Eagle Materials Inc: financial statements, quarterly

EXP · NYSE · CIK 918646 · [Materials](/sectors/materials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/exp.md) · [Financials](/companies/exp/financials.md) · [Filings](/companies/exp/filings.md) · [Insiders](/companies/exp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/exp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [622](/filings/0000950170-24-118307.md) | [559](/filings/0000950170-25-010557.md) | [477 d](/filings/0001193125-26-230979.md) | [609](/filings/0000950170-25-099771.md) | [624](/filings/0001193125-25-258663.md) | [558](/filings/0001193125-26-029491.md) | [470 d](/filings/0001193125-26-230979.md) | [635](/filings/0001193125-26-323823.md) | [639](/filings/0001193125-25-258663.md) | [556](/filings/0001193125-26-029491.md) | [479 d](/filings/0001193125-26-230979.md) | [651](/filings/0001193125-26-323823.md) |
| Cost of revenue | $m | [413](/filings/0000950170-24-118307.md) | [378](/filings/0000950170-25-010557.md) | [357 d](/filings/0001193125-26-230979.md) | [422](/filings/0000950170-25-099771.md) | [420](/filings/0001193125-25-258663.md) | [380](/filings/0001193125-26-029491.md) | [366 d](/filings/0001193125-26-230979.md) | [449](/filings/0001193125-26-323823.md) | [439](/filings/0001193125-25-258663.md) | [395](/filings/0001193125-26-029491.md) | [373 d](/filings/0001193125-26-230979.md) | [490](/filings/0001193125-26-323823.md) |
| Gross profit | $m | [209](/filings/0000950170-24-118307.md) | [181](/filings/0000950170-25-010557.md) | [120 d](/filings/0001193125-26-230979.md) | [187](/filings/0000950170-25-099771.md) | [204](/filings/0001193125-25-258663.md) | [178](/filings/0001193125-26-029491.md) | [105 d](/filings/0001193125-26-230979.md) | [186](/filings/0001193125-26-323823.md) | [200](/filings/0001193125-25-258663.md) | [161](/filings/0001193125-26-029491.md) | [106 d](/filings/0001193125-26-230979.md) | [161](/filings/0001193125-26-323823.md) |
| Operating income | $m | [219](/filings/0000950170-24-118307.md) | [190](/filings/0000950170-25-010557.md) | [128 d](/filings/0000950170-24-063523.md) | [195](/filings/0000950170-24-087945.md) | [213](/filings/0000950170-24-118307.md) | [183](/filings/0000950170-25-010557.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [10.2](/filings/0000950170-24-118307.md) | [10.1](/filings/0000950170-25-010557.md) | [9.7 d](/filings/0001193125-26-230979.md) | [10.7](/filings/0000950170-25-099771.md) | [10.7](/filings/0001193125-25-258663.md) | [9.1](/filings/0001193125-26-029491.md) | [10.1 d](/filings/0001193125-26-230979.md) | [11.7](/filings/0001193125-26-323823.md) | [9.4](/filings/0001193125-25-258663.md) | [13.7](/filings/0001193125-26-029491.md) | [11.7 d](/filings/0001193125-26-230979.md) | [12.9](/filings/0001193125-26-323823.md) |
| Income tax | $m | [43.6](/filings/0000950170-24-118307.md) | [37.5](/filings/0000950170-25-010557.md) | [24.6 d](/filings/0001193125-26-230979.md) | [37.1](/filings/0000950170-25-099771.md) | [41.7](/filings/0001193125-25-258663.md) | [34.7](/filings/0001193125-26-029491.md) | [14.5 d](/filings/0001193125-26-230979.md) | [34.5](/filings/0001193125-26-323823.md) | [39.1](/filings/0001193125-25-258663.md) | [26.3](/filings/0001193125-26-029491.md) | [18.2 d](/filings/0001193125-26-230979.md) | [29.6](/filings/0001193125-26-323823.md) |
| Net income | $m | [151](/filings/0000950170-25-010557.md) | [129](/filings/0000950170-25-010557.md) | [77.1 d](/filings/0001193125-26-230979.md) | [134](/filings/0001193125-26-029491.md) | [144](/filings/0001193125-26-029491.md) | [120](/filings/0001193125-26-029491.md) | [66.5 d](/filings/0001193125-26-230979.md) | [123](/filings/0001193125-26-323823.md) | [137](/filings/0001193125-26-029491.md) | [103](/filings/0001193125-26-029491.md) | [60.2 d](/filings/0001193125-26-230979.md) | [102](/filings/0001193125-26-323823.md) |
| Diluted EPS | $ per share | [4.26](/filings/0000950170-24-118307.md) | [3.72](/filings/0000950170-25-010557.md) | not reported | [3.94](/filings/0000950170-25-099771.md) | [4.26](/filings/0001193125-25-258663.md) | [3.56](/filings/0001193125-26-029491.md) | not reported | [3.76](/filings/0001193125-26-323823.md) | [4.23](/filings/0001193125-25-258663.md) | [3.22](/filings/0001193125-26-029491.md) | not reported | [3.29](/filings/0001193125-26-323823.md) |
| Basic EPS | $ per share | [4.29](/filings/0000950170-24-118307.md) | [3.75](/filings/0000950170-25-010557.md) | not reported | [3.97](/filings/0000950170-25-099771.md) | [4.29](/filings/0001193125-25-258663.md) | [3.59](/filings/0001193125-26-029491.md) | not reported | [3.78](/filings/0001193125-26-323823.md) | [4.25](/filings/0001193125-25-258663.md) | [3.23](/filings/0001193125-26-029491.md) | not reported | [3.30](/filings/0001193125-26-323823.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [47.3](/filings/0000950170-23-055671.md) | [48.9](/filings/0000950170-24-007463.md) | [34.9](/filings/0000950170-25-075321.md) | [46.5](/filings/0000950170-24-087945.md) | [93.9](/filings/0000950170-24-118307.md) | [31.2](/filings/0000950170-25-010557.md) | [20.4](/filings/0001193125-26-230979.md) | [59.7](/filings/0000950170-25-099771.md) | [35.0](/filings/0001193125-25-258663.md) | [419](/filings/0001193125-26-029491.md) | [298](/filings/0001193125-26-323823.md) | [234](/filings/0001193125-26-323823.md) |
| Current assets | $m | [612](/filings/0000950170-23-055671.md) | [588](/filings/0000950170-24-007463.md) | [628](/filings/0000950170-25-075321.md) | [713](/filings/0000950170-24-087945.md) | [730](/filings/0000950170-24-118307.md) | [618](/filings/0000950170-25-010557.md) | [669](/filings/0001193125-26-230979.md) | [732](/filings/0000950170-25-099771.md) | [671](/filings/0001193125-25-258663.md) | [1,032](/filings/0001193125-26-029491.md) | [951](/filings/0001193125-26-323823.md) | [929](/filings/0001193125-26-323823.md) |
| Total assets | $m | [2,917](/filings/0000950170-23-055671.md) | [2,890](/filings/0000950170-24-007463.md) | [2,947](/filings/0001193125-26-230979.md) | [3,043](/filings/0000950170-24-087945.md) | [3,122](/filings/0000950170-24-118307.md) | [3,044](/filings/0000950170-25-010557.md) | [3,265](/filings/0001193125-26-230979.md) | [3,397](/filings/0000950170-25-099771.md) | [3,409](/filings/0001193125-25-258663.md) | [3,843](/filings/0001193125-26-029491.md) | [3,842](/filings/0001193125-26-323823.md) | [3,908](/filings/0001193125-26-323823.md) |
| Current liabilities | $m | [225](/filings/0000950170-23-055671.md) | [226](/filings/0000950170-24-007463.md) | [239](/filings/0000950170-25-075321.md) | [291](/filings/0000950170-24-087945.md) | [312](/filings/0000950170-24-118307.md) | [224](/filings/0000950170-25-010557.md) | [245](/filings/0001193125-26-230979.md) | [268](/filings/0000950170-25-099771.md) | [247](/filings/0001193125-25-258663.md) | [242](/filings/0001193125-26-029491.md) | [260](/filings/0001193125-26-323823.md) | [288](/filings/0001193125-26-323823.md) |
| Total liabilities | $m | [1,610](/filings/0000950170-23-055671.md) | [1,557](/filings/0000950170-24-007463.md) | [1,638](/filings/0000950170-25-075321.md) | [1,692](/filings/0000950170-24-087945.md) | [1,690](/filings/0000950170-24-118307.md) | [1,548](/filings/0000950170-25-010557.md) | [1,808](/filings/0001193125-26-230979.md) | [1,906](/filings/0000950170-25-099771.md) | [1,872](/filings/0001193125-25-258663.md) | [2,350](/filings/0001193125-26-029491.md) | [2,367](/filings/0001193125-26-323823.md) | [2,421](/filings/0001193125-26-323823.md) |
| Long-term debt | $m | [1,080](/filings/0000950170-23-055671.md) | [1,022](/filings/0000950170-24-007463.md) | [1,083](/filings/0000950170-25-075321.md) | [1,091](/filings/0000950170-24-087945.md) | [1,064](/filings/0000950170-24-118307.md) | [992](/filings/0000950170-25-010557.md) | [1,223](/filings/0001193125-26-230979.md) | [1,295](/filings/0000950170-25-099771.md) | [1,271](/filings/0001193125-25-258663.md) | [1,748](/filings/0001193125-26-029491.md) | [1,745](/filings/0001193125-26-323823.md) | [1,742](/filings/0001193125-26-323823.md) |
| Current portion of debt | $m | [10.0](/filings/0000950170-23-055671.md) | [10.0](/filings/0000950170-24-007463.md) | [10.0](/filings/0000950170-25-075321.md) | [10.0](/filings/0000950170-24-087945.md) | [10.0](/filings/0000950170-24-118307.md) | [10.0](/filings/0000950170-25-010557.md) | [15.0](/filings/0001193125-26-230979.md) | [15.0](/filings/0000950170-25-099771.md) | [15.0](/filings/0001193125-25-258663.md) | [15.0](/filings/0001193125-26-029491.md) | [15.0](/filings/0001193125-26-323823.md) | [15.0](/filings/0001193125-26-323823.md) |
| Shareholders' equity | $m | [1,307](/filings/0000950170-25-010557.md) | [1,333](/filings/0000950170-25-010557.md) | [1,309](/filings/0001193125-26-230979.md) | [1,351](/filings/0001193125-26-029491.md) | [1,432](/filings/0001193125-26-029491.md) | [1,496](/filings/0001193125-26-029491.md) | [1,457](/filings/0001193125-26-323823.md) | [1,492](/filings/0001193125-26-323823.md) | [1,537](/filings/0001193125-26-029491.md) | [1,494](/filings/0001193125-26-029491.md) | [1,475](/filings/0001193125-26-323823.md) | [1,487](/filings/0001193125-26-323823.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [172 d](/filings/0000950170-24-118307.md) | [188 d](/filings/0000950170-25-010557.md) | [63.4 d](/filings/0001193125-26-230979.md) | [133](/filings/0000950170-25-099771.md) | [233 d](/filings/0001193125-25-258663.md) | [120 d](/filings/0001193125-26-029491.md) | [62.8 d](/filings/0001193125-26-230979.md) | [137](/filings/0001193125-26-323823.md) | [205 d](/filings/0001193125-25-258663.md) | [171 d](/filings/0001193125-26-029491.md) | [102 d](/filings/0001193125-26-230979.md) | [154](/filings/0001193125-26-323823.md) |
| Capital expenditure | $m | [29.5 d](/filings/0000950170-24-118307.md) | [22.4 d](/filings/0000950170-25-010557.md) | [32.5 d](/filings/0001193125-26-230979.md) | [33.1](/filings/0000950170-25-099771.md) | [66.5 d](/filings/0001193125-25-258663.md) | [47.4 d](/filings/0001193125-26-029491.md) | [48.3 d](/filings/0001193125-26-230979.md) | [76.1](/filings/0001193125-26-323823.md) | [109 d](/filings/0001193125-25-258663.md) | [110 d](/filings/0001193125-26-029491.md) | [122 d](/filings/0001193125-26-230979.md) | [121](/filings/0001193125-26-323823.md) |
| Dividends paid | $m | [8.9 d](/filings/0000950170-24-118307.md) | [8.8 d](/filings/0000950170-25-010557.md) | [8.6 d](/filings/0001193125-26-230979.md) | [8.5](/filings/0000950170-25-099771.md) | [8.5 d](/filings/0001193125-25-258663.md) | [8.4 d](/filings/0001193125-26-029491.md) | [8.3 d](/filings/0001193125-26-230979.md) | [8.3](/filings/0001193125-26-323823.md) | [8.4 d](/filings/0001193125-25-258663.md) | [7.8 d](/filings/0001193125-26-029491.md) | [7.9 d](/filings/0001193125-26-230979.md) | [8.0](/filings/0001193125-26-323823.md) |
| Share repurchases | $m | [77.3 d](/filings/0000950170-24-118307.md) | [97.5 d](/filings/0000950170-25-010557.md) | [94.4 d](/filings/0001193125-26-230979.md) | [85.5](/filings/0000950170-25-099771.md) | [60.7 d](/filings/0001193125-25-258663.md) | [55.1 d](/filings/0001193125-26-029491.md) | [97.0 d](/filings/0001193125-26-230979.md) | [78.6](/filings/0001193125-26-323823.md) | [89.1 d](/filings/0001193125-25-258663.md) | [143 d](/filings/0001193125-26-029491.md) | [71.5 d](/filings/0001193125-26-230979.md) | [83.8](/filings/0001193125-26-323823.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [37.4](/filings/0000950170-23-055671.md) | [36.6](/filings/0000950170-24-007463.md) | [35.5](/filings/0000950170-24-087945.md) | [35.3](/filings/0000950170-24-118307.md) | [34.7](/filings/0000950170-25-010557.md) | [34.0](/filings/0000950170-25-099771.md) | [33.7](/filings/0001193125-25-258663.md) | [33.6](/filings/0001193125-26-029491.md) | [32.8](/filings/0001193125-26-323823.md) | [32.5](/filings/0001193125-25-258663.md) | [32.0](/filings/0001193125-26-029491.md) | [31.1](/filings/0001193125-26-323823.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 30,675,325 at 2026-07-25, from the cover of the [10-Q filed 2026-07-29](/filings/0001193125-26-323823.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.